United States News All stories

Blaize (NASDAQ:BZAI) expects preliminary third-quarter 2026 revenue of approximately $0.5 million as quarter-end closing procedures continue.

Greenbrier (NYSE:GBX) strongly rejected antidumping and countervailing duty petitions filed by Berkshire Hathaway (NYSE:BRK.A) subsidiary UTLX Manufacturing regarding railway tank cars.

Taiwan Semiconductor Manufacturing Company (NYSE:TSM) reached an intraday stock high following confirmed factory partnership discussions.

Qualcomm (NASDAQ:QCOM) initiated a federal trial in Delaware to freeze royalty payments to Arm Holdings (NASDAQ:ARM) for up to five years over alleged contract breaches.

Crescent Biopharma (NASDAQ:CBIO) received FDA clearance for its Investigational New Drug application for CR-002, an antibody-drug conjugate being developed for advanced solid tumors.

Alterity Therapeutics (NASDAQ:ATHE) reported additional Phase 2 analyses showing ATH434 50 mg slowed functional decline in multiple system atrophy by approximately 52% compared with placebo at Week 52.

TeraWulf (NASDAQ:WULF) secured expanded electrical capacity to accelerate development at its Muskie Data Campus.

Datasea (NASDAQ:DTSS) released its full-year financial performance for the period ending June 30, 2026, highlighting improved profitability metrics alongside top-line adjustments.

Fathom Holdings (NASDAQ:FTHM) and Neighborhood Intelligence (NASDAQ:NXH) called off their planned corporate combination after respective boards reviewed current market valuations and shareholder feedback.

Gilat (NASDAQ:GILT) expanded its Latin American telecommunications footprint through a new agreement between its local Peruvian subsidiary and Peru's national telecommunications program, Pronatel.

Construction Partners (NASDAQ:ROAD) expanded its regional operating footprint by closing the acquisition of asphalt and construction assets from Tye, Texas-based J.H. Strain & Sons.

NeuroOne (NASDAQ:NMTC) reported unaudited preliminary financial figures for the fiscal fourth quarter and full-year period ending September 30, 2026.

Abbott (NYSE:ABT) received regulatory clearance from the U.S. Food and Drug Administration for major software capabilities connected to its implanted heart-monitoring platform.

TELUS (NYSE:TU) finalized a key technical milestone alongside AST SpaceMobile by testing direct satellite connectivity with standard mobile devices.

INNOVATE (NYSE:VATE) finalized the divestiture of its majority interest in DBM Global to IES Holdings (NASDAQ:IESC).

Skyworks (NASDAQ:SWKS) finalized its strategic combination with Qorvo, uniting two major players in radio frequency, analog, and power semiconductor solutions.

Clean Harbors (NYSE:CLH) completed the acquisitions of EnviroServe and ES&H for a combined purchase price of $775 million in cash and senior notes.

DoorDash (NASDAQ:DASH) brand Deliveroo partnered with Coco Robotics to launch autonomous robot deliveries across the UK beginning in Canary Wharf, London, in October.

Establishment Labs Holdings (NASDAQ:ESTA) secured U.S. Food and Drug Administration approval for an expanded range of Motiva SmoothSilk Round and Ergonomix breast implants.

GE HealthCare (NASDAQ:GEHC) executed a definitive agreement to acquire SOFIE Biosciences from Trilantic North America for a cash purchase price of $945 million.

Alector (NASDAQ:ALEC) executed an exclusive global licensing agreement with Genentech for AL050, an investigational enzyme replacement therapy targeting Parkinson’s disease.

Harrow (NASDAQ:HROW) closed the acquisition of TYRVAYA from Viatris to expand its commercial ophthalmic portfolio with an approved dry eye treatment.

Rezolute (NASDAQ:RZLT) announced that the U.S. Food and Drug Administration recommended a pre-BLA meeting prior to any potential biologics license application for ersodetug.

Stoke Therapeutics (NASDAQ:STOK) announced the successful completion of a meeting with the U.S. Food and Drug Administration regarding its investigational zorevunersen treatment.